In advanced hepatocellular carcinoma (HCC) without knowledge of PD-L1 expression levels, the median survival time of patients was less than 1 year, and the median survival time with PD-1 inhibitor immunotherapy alone reached 15.6 months [10, 11]. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.